|
|
|
|
LEADER |
01000naa a22002652 4500 |
001 |
NLM24185279X |
003 |
DE-627 |
005 |
20231224125135.0 |
007 |
cr uuu---uuuuu |
008 |
231224s2014 xx |||||o 00| ||eng c |
028 |
5 |
2 |
|a pubmed24n0806.xml
|
035 |
|
|
|a (DE-627)NLM24185279X
|
035 |
|
|
|a (NLM)25215871
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a eng
|
100 |
1 |
|
|a Jain, Nieraj
|e verfasserin
|4 aut
|
245 |
1 |
0 |
|a Vitrectomy alone in the management of giant retinal tears
|
264 |
|
1 |
|c 2014
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
500 |
|
|
|a Date Completed 27.10.2015
|
500 |
|
|
|a Date Revised 21.03.2022
|
500 |
|
|
|a published: Print
|
500 |
|
|
|a Citation Status MEDLINE
|
520 |
|
|
|a BACKGROUND AND OBJECTIVE: To evaluate the outcomes of vitrectomy without adjuvant scleral buckling for giant retinal tear (GRT) detachment and assess the impact of preoperative lens status on these outcomes
|
520 |
|
|
|a PATIENTS AND METHODS: Retrospective review of consecutive cases of vitrectomy alone for primary GRT detachment at the University of Michigan from October 1992 through October 2012. The primary outcome measure was Kaplan-Meier–estimated single-surgery reattachment rate at 3 months
|
520 |
|
|
|a RESULTS: Eligibility criteria were met by 41 eyes of 40 patients. Six eyes (15%) had grade C proliferative vitreoretinopathy at baseline. The single-surgery reattachment rate was 83% (95% CI: 67%, 91%) at 3 months, with no significant difference between phakic and nonphakic eyes
|
520 |
|
|
|a CONCLUSION: Based on this retrospective series, and within the confines of our eligibility criteria, adjuvant scleral buckling does not appear to be necessary in the management of primary GRT detachment
|
650 |
|
4 |
|a Journal Article
|
650 |
|
4 |
|a Research Support, Non-U.S. Gov't
|
700 |
1 |
|
|a Kozak, Jennifer A
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Niziol, Leslie M
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Musch, David C
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Zacks, David N
|e verfasserin
|4 aut
|
773 |
0 |
8 |
|i Enthalten in
|t Ophthalmic surgery, lasers & imaging retina
|d 2013
|g 45(2014), 5 vom: 06. Sept., Seite 421-7
|w (DE-627)NLM224956647
|x 2325-8179
|7 nnns
|
773 |
1 |
8 |
|g volume:45
|g year:2014
|g number:5
|g day:06
|g month:09
|g pages:421-7
|
912 |
|
|
|a GBV_USEFLAG_A
|
912 |
|
|
|a SYSFLAG_A
|
912 |
|
|
|a GBV_NLM
|
912 |
|
|
|a GBV_ILN_24
|
912 |
|
|
|a GBV_ILN_31
|
912 |
|
|
|a GBV_ILN_40
|
912 |
|
|
|a GBV_ILN_63
|
912 |
|
|
|a GBV_ILN_65
|
912 |
|
|
|a GBV_ILN_69
|
912 |
|
|
|a GBV_ILN_70
|
912 |
|
|
|a GBV_ILN_90
|
912 |
|
|
|a GBV_ILN_91
|
912 |
|
|
|a GBV_ILN_130
|
912 |
|
|
|a GBV_ILN_135
|
912 |
|
|
|a GBV_ILN_136
|
912 |
|
|
|a GBV_ILN_151
|
912 |
|
|
|a GBV_ILN_181
|
912 |
|
|
|a GBV_ILN_203
|
912 |
|
|
|a GBV_ILN_217
|
912 |
|
|
|a GBV_ILN_235
|
912 |
|
|
|a GBV_ILN_289
|
912 |
|
|
|a GBV_ILN_294
|
912 |
|
|
|a GBV_ILN_297
|
912 |
|
|
|a GBV_ILN_350
|
912 |
|
|
|a GBV_ILN_352
|
912 |
|
|
|a GBV_ILN_674
|
912 |
|
|
|a GBV_ILN_676
|
912 |
|
|
|a GBV_ILN_688
|
912 |
|
|
|a GBV_ILN_698
|
912 |
|
|
|a GBV_ILN_721
|
912 |
|
|
|a GBV_ILN_737
|
912 |
|
|
|a GBV_ILN_791
|
912 |
|
|
|a GBV_ILN_812
|
951 |
|
|
|a AR
|
952 |
|
|
|d 45
|j 2014
|e 5
|b 06
|c 09
|h 421-7
|